Erythropoietin Attenuates Experimental Contrast-Induced Nephrology: A Role for the Janus Kinase 2/Signal Transducer and Activator of Transcription 3 Signaling Pathway
Open Access
- 13 April 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Medicine
Abstract
The aim of the present study was to investigate the effect of erythropoietin (EPO) on contrast-induced nephrology (CIN) in vivo and in vitro. Male C57BL/6J mice were divided into four groups: control, CIN (iohexol 6.0 g/kg), EPO (3,000 IU/kg), and CIN+EPO. Hematoxylin and eosin (H&E) staining and biochemical index analyses were performed to evaluate renal injury. The cellular proliferation rate was detected using the Cell Counting Kit-8 (CCK-8) assay. In addition, a terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay and flow cytometric assay were used to assess the apoptosis of tissue and cells, respectively. Renal protein expression associated with apoptosis, pyroptosis, and signaling pathways was determined by Western blot (WB) assays for tissues and cells. The results showed that EPO significantly decreased serum creatinine, blood urea nitrogen, and cystatin C levels and alleviated renal histological changes in vivo. The protein levels of Janus kinase 2/signal transducer and activator of transcription 3 (JAK2/STAT3) signaling pathway components were overexpressed in the EPO treatment group. Furthermore, EPO suppressed the cell apoptosis and pyroptosis; decreased the protein levels of cleaved caspase-3, Bax, gasdermin D (GSDMD), and caspase-1; and enhanced the expression of Bcl-2. In summary, EPO could exert renoprotective effect by activating the JAK2/STAT3 signaling pathway, which may be a novel potential therapy for the treatment of CIN in the clinic.This publication has 39 references indexed in Scilit:
- Advances in the pathogenesis and prevention of contrast-induced nephropathyLife Sciences, 2020
- Acute Renal Failure/Acute Kidney Injury (AKI) Associated with Endovascular ProceduresDiagnostics, 2020
- Treatment of Neonatal Hypoxic-Ischemic Encephalopathy with Erythropoietin Alone, and Erythropoietin Combined with Hypothermia: History, Current Status, and Future ResearchInternational Journal of Molecular Sciences, 2020
- Gasdermin D and pyroptosis in acute kidney injuryKidney International, 2019
- Intramyocardial angiogenetic stem cells and epicardial erythropoietin save the acute ischemic heartDisease Models & Mechanisms, 2018
- JAK/STAT – Emerging Players in MetabolismTrends in Endocrinology & Metabolism, 2018
- Characterising the Role of Perioperative Erythropoietin for Preventing Acute Kidney Injury after Cardiac Surgery: Systematic Review and Meta-AnalysisHeart, Lung and Circulation, 2016
- Acute Kidney Injury Network definition of contrast-induced nephropathy in the critically ill: Incidence and outcomeJournal of Critical Care, 2011
- Contrast-Induced NephropathyAmerican Journal of Roentgenology, 2004
- Hospital-acquired renal insufficiencyAmerican Journal of Kidney Diseases, 2002